DEXAMETHASONE IMPLANT VERSUS TOPICAL CARBONIC ANHYDRASE INHIBITORS IN PATIENTS WITH BILATERAL RETINITIS PIGMENTOSA-RELATED CYSTOID MACULAR EDEMA: A Prospective, Paired-Eye Pilot Study.

Central macular thickness was significantly lower in intravitreal dexamethasone implant–treated eyes than in topical carbonic anhydrase inhibitors–treated eyes at Months 1 and 7, whereas mean best-corrected visual acuity was better in eyes treated with topical carbonic anhydrase inhibitors at Month 12 (borderline significant P = 0.0510).

also in 11,409 other papers

However, this failed to reach statistical significance: the difference in mean BCVA between the two groups showed a borderline P -value, in favor of topical CAI, at month 12.

also in 6,035 other papers